| LGLCX | RGEBX | LGLCX / RGEBX | |
| Total Expense Ratio | 1.64 | 1.08 | 152% |
| Annual Report Gross Expense Ratio | 1.64 | 1.08 | 152% |
| Fund Existence | 15 years | 12 years | - |
| Gain YTD | 2.232 | 5.309 | 42% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1500 | 250 | 600% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.43B | 357B | 2% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 2.80 | 0.66 | 424% |
| Returns for 3 years | 73.19 | 32.78 | 223% |
| Returns for 5 years | 6.44 | 9.78 | 66% |
| Returns for 10 years | 111.23 | 90.83 | 122% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MAGCX | 35.22 | 0.18 | +0.51% |
| BlackRock Advantage Global Institutional | |||
| PGINX | 24.22 | 0.10 | +0.41% |
| Impax Global Environmental Markets Instl | |||
| PMVQX | 33.83 | -0.09 | -0.27% |
| PGIM Quant Solutions Mid-Cap Val R6 | |||
| RYCMX | 55.80 | -0.43 | -0.76% |
| Rydex Russell 2000 1.5x Strategy C | |||
| SHSKX | 67.59 | -0.74 | -1.08% |
| BlackRock Health Sciences Opps K | |||